ASND - Ascendis Pharma A/S -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg ยท closes rebased to 100 at each year's first session
Ticker Details
Ascendis Pharma A/S
Ascendis Pharma A/S is a biotechnology company that applies its TransCon technology to develop a pipeline of prodrug therapies with profiles that address markets with unmet medical needs.
IPO Date: July 11, 2008
Sector: Healthcare
Industry: Biotech
Market Cap: $14.69B
Activated in VL: True
Average Daily Range
Avg Daily Range: $2.09 | 2.03%
Avg Daily Range (30 D): $4.41 | 1.81%
Avg Daily Range (90 D): $4.45 | 1.81%
Institutional Daily Volume
Avg Daily Volume: .28M
Avg Daily Volume (30 D): .71M
Avg Daily Volume (90 D): .57M
Trade Size
Avg Trade Size (Sh.): 64
Avg Trade Size (Sh.) (30 D): 45
Avg Trade Size (Sh.) (90 D): 44
Institutional Trades
Total Institutional Trades: 10,464
Avg Institutional Trade: $2.47M
Avg Institutional Trade (30 D): $4.31M
Avg Institutional Trade (90 D): $4.5M
Avg Institutional Trade Volume: .02M
Avg Institutional Trades (Per Day): 5
Market Closing Trades
Avg Closing Trade: $4.55M
Avg Closing Trade (30 D): $23.77M
Avg Closing Trade (90 D): $24.58M
Avg Closing Volume: 26.23K
 
News
Oct 7, 2026 @ 2:37 PM
FDA Grants Priority Review to BridgeBio's Dwarfism...
Source: Na
Sep 16, 2026 @ 4:01 PM
BioMarin Stops Voxzogo Development for Noonan Synd...
Source: Na
Sep 14, 2026 @ 10:00 PM
Ascendis Announces Planned $400 Million Share Repu...
Source: Na
Sep 3, 2026 @ 4:28 PM
How BioMarin Turned a Competitive Threat Into a Ro...
Source: Zacks.Com
Jun 30, 2026 @ 4:26 AM
Big Pharma Has a Case of Merger Mania
Source: Motley Fool Staff